Design expert software assisted development and evaluation of empagliflozin and sitagliptin combination tablet with improved in-vivo anti-diabetic activities-Reference-Cited by-同舟云学术

Design expert software assisted development and evaluation of empagliflozin and sitagliptin combination tablet with improved in-vivo anti-diabetic activities

Published:2023-03 Issue:3 Volume:9 Page:e14259
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Hossain Md Saddam,Jahan Sadia,Al Rezwan Rahman Sad,Rahman Mashiur^ORCID,Kumar Diponkor^ORCID,Paul Susmita,Chandra Rajbangshi Joy

Funder

University Grants Commission of Bangladesh

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference58 articles.

1. Type 2 diabetes;Chatterjee;Lancet,2017

2. Use of oral combination therapy for type 2 diabetes in primary care: meeting individualized patient goals;Lavernia;Postgrad. Med.,2015

3. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015

4. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement;Garber;Endocr. Pract.,2013

5. Empagliflozin/Linagliptin: combination therapy in patients with type 2 diabetes;Tan,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental study on the sugarcane stubble base-cutting mechanism;Biosystems Engineering;2024-09

2. Design and optimization of the seed conveying system for belt-type high-speed corn seed guiding device;International Journal of Agricultural and Biological Engineering;2024